Publications by authors named "Marta Anton-Juanilla"

Background: Patient factors associated with urinary tract cancer can be used to risk stratify patients referred with haematuria, prioritising those with a higher risk of cancer for prompt investigation.

Objective: To develop a prediction model for urinary tract cancer in patients referred with haematuria.

Design, Setting, And Participants: A prospective observational study was conducted in 10 282 patients from 110 hospitals across 26 countries, aged ≥16 yr and referred to secondary care with haematuria.

View Article and Find Full Text PDF

Objective: Calcification and atherosclerosis of the iliac arteries is very common in dialysis patients, making sometimes impossible the anastomosis of a kidney graft. The objective of this study is to present our kidney transplantation series using vascular prostheses for iliacartery reconstruction and to assess the results obtained in comparison to other published series.

Material And Method: In a single centre where 1090 kidney transplants were performed between January 2013 and December 2019, patients who required vascular reconstruction were identified for their descriptive analysis.

View Article and Find Full Text PDF

Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tract urothelial cancer [UTUC] and renal cancer) in patients referred to secondary care with haematuria, adjusted for established patient risk markers and geographical variation.

Patients And Methods: This was an international multicentre prospective observational study. We included patients aged ≥16 years, referred to secondary care with suspected urinary tract cancer.

View Article and Find Full Text PDF
Article Synopsis
  • This review highlights the role of prostate specific membrane antigen (PSMA) radioligand therapy (RLT) as a potential new treatment for advanced prostate cancer, especially for those with metastatic castrate-resistant prostate cancer (mCRPC).
  • Current data supports the use of small-molecule PSMA inhibitors, particularly Lu-PSMA, showing promising safety and effectiveness in heavily pre-treated patients.
  • Ongoing clinical trials are exploring the theranostic approach's impact, suggesting it could play a crucial role not only in advanced stages of the disease but also in earlier stages of prostate cancer.
View Article and Find Full Text PDF

The COVID-19 pandemic has seriously disrupted the day-to-day running of hospitals, affecting the activity of all medical and surgical departments. It has also affected urology residents, depriving them of training at their usual workplaces and forcing them to support COVID units. This has implied not only the loss of daily activities, but also the uncertainty of job opportunities for the final year residents.

View Article and Find Full Text PDF

Objective: Among western males, prostate cancer is the most frequent oncological disease. Since the widespread of PSA, diagnoses in younger adults is increasing. The aim of this study is to analyze pathological features and biochemical recurrence event in patients ≤55 years who underwent robotic radical prostatectomy (RRP) surgery.

View Article and Find Full Text PDF